p53 destabilizing protein skews asymmetric division and enhances NOTCH activation to direct self-renewal of TICs.
Hye Yeon ChoiHifzur R SiddiqueMengmei ZhengYi KouDa-Wei YehTatsuya MachidaChia-Lin ChenDinesh Babu Uthaya KumarVasu PunjPeleg WinerAlejandro PitaLinda SherStanley M TaharaRatna B RayChengyu LiangLin ChenHidekazu TsukamotoKeigo MachidaPublished in: Nature communications (2020)
Tumor-initiating stem-like cells (TICs) are defective in maintaining asymmetric cell division and responsible for tumor recurrence. Cell-fate-determinant molecule NUMB-interacting protein (TBC1D15) is overexpressed and contributes to p53 degradation in TICs. Here we identify TBC1D15-mediated oncogenic mechanisms and tested the tumorigenic roles of TBC1D15 in vivo. We examined hepatocellular carcinoma (HCC) development in alcohol Western diet-fed hepatitis C virus NS5A Tg mice with hepatocyte-specific TBC1D15 deficiency or expression of non-phosphorylatable NUMB mutations. Liver-specific TBC1D15 deficiency or non-p-NUMB expression reduced TIC numbers and HCC development. TBC1D15-NuMA1 association impaired asymmetric division machinery by hijacking NuMA from LGN binding, thereby favoring TIC self-renewal. TBC1D15-NOTCH1 interaction activated and stabilized NOTCH1 which upregulated transcription of NANOG essential for TIC expansion. TBC1D15 activated three novel oncogenic pathways to promote self-renewal, p53 loss, and Nanog transcription in TICs. Thus, this central regulator could serve as a potential therapeutic target for treatment of HCC.
Keyphrases
- transcription factor
- hepatitis c virus
- poor prognosis
- binding protein
- obsessive compulsive disorder
- cell proliferation
- cell fate
- physical activity
- type diabetes
- risk assessment
- south africa
- single cell
- amino acid
- human immunodeficiency virus
- weight loss
- solid state
- stem cells
- metabolic syndrome
- adipose tissue
- zika virus
- dna binding
- human health
- bone marrow
- deep brain stimulation
- combination therapy
- cell therapy
- wild type